Medical Device Playbook, Canada’s premiere event for medical device professionals, is returning to the Vancouver Terminal City Club on May 23, 2018.
Industry speakers and panels from British Columbia and across North America will discuss what it takes to achieve this year’s theme: Dream a Bigger Dream. Network and learn 2018 trends, opportunities, and strategies. Entrepreneur Case Studies, Human Factors and Design, and Clinical/Regulatory advice from industry veterans.
Event includes Lunch, Breaks, and Networking Reception. All net proceeds will go to LifeSciences BC for future medtech initiatives.
MITCH LEVINSON, Co-Founder, President and CEO at Cerebrotech - San Francisco
Serial Medtech entrepreneur and inventor of over 40 issued and numerous pending U.S. patents
Mitchell E. Levinson is currently President and Chief Executive Officer of Cerebrotech Medical Systems, a start-up medical device company he co-founded in 2010 focusing on noninvasive neuro-monitoring for early detection of stroke, cerebral bleeding and edema. Prior to 2010, Mr. Levinson was the start-up CEO for Zeltiq Aesthetics Inc. (the CoolSculpting company) when he became its first employee in 2005, and served as its president and its chief executive officer from September 2005 until September 2009. He continued with Zeltiq as Chief Scientific Officer from September 2009 through December 2010 to help transition the company. From March 2000 to September 2005 he served as Vice President of Research and Development of Thermage, Inc. (IPO, then acquired by Valiant), a company engaged in cosmetic tissue tightening devices. He held a similar position at BioSurgical Corp, a surgical sealant applicator company which was acquired by Baxter. Prior to that he held engineering and management positions at Nellcor, Baxter and HP. Mr. Levinson is the inventor of over 40 issued and numerous pending U.S. patents. Mr. Levinson earned his BS in Mechanical Engineering from University of California at San Diego and holds an M.S in Computer Systems from the University of Phoenix. Mr. Levinson has been a member of the board of directors at Pulse Biosciences (IPO 2016) and CryOSA, both companies focused on non-invasive tissue ablation.
Cerebrotech: A company “designed” to survive an unforgiving financing environment
Learn how I used an engineering approach to “design” my fledgling startup to survive.
VIRGINIA A. LANG, President and Chief Scientist, HirLan, Inc. and HirLan International SA - Carlsbad CA
Human Factors Pioneer
Virginia started in the medical research field as a Coordinator of Research at the Clinical Research Unit Kennedy Institute of Johns Hopkins Medical Center. She was responsible for the initiation, coordination, and management and/or analysis of research projects in the Clinical Research Unit. These projects were funded by various Federal Government Agencies. Subsequent to working at Johns Hopkins Medical Center, Virginia entered the field of Human Factors through the doctoral program at SUNY Binghamton. Virginia held a fellowship at the Aeromedical Research Laboratory of the United States Air Force at Wright-Patterson AFB, Dayton, Ohio and a fellowship at NASA. Her research dealt with cognitive factors that differentially affect the characteristics of visual displays. Applications of this research are directly related to various medical devices and software applications providing Medical Device Human Factors by HirLan clients with 30 years of Human Factors experience.
In addition, Virginia has extensive experience in the areas of product design, Customer Centered Participatory Design processes, and product lifecycle management. She is also known in the Human Computer Interaction and Usability Communities for her innovative techniques for collecting and incorporating user/customer feedback throughout the product lifecycle. In July 2014, Virginia founded and established the HirLan Institute of Human Factors with labs in Carlsbad, California and a Consortium arrangement in London, UK. In February 2013, Virginia founded HirLan International SA, a Geneva, Switzerland based company. Both HirLan and HirLan International have been supporting Top Ten pharma/medical device companies, as well as, start-ups with consulting and testing services. These services are in conjunction with their clients’ FDA 510(k) and CE mark applications.
Virginia holds a PhD in Cognitive-Experimental Psychology from SUNY Binghamton, and a Master of Science (ABT) in Applied Technology, Systems Science from SUNY Binghamton.
Human Factors is good business -- not an obstacle!
MIKE TOTTERMAN, CEO and co-founder of Clerio Vision - Rochester NY
Co-founded iCardiac Technologies, and VirtualScopics; former principal at 3Com Ventures
Mike is CEO and co-founder of Clerio Vision. The company is developing a novel approach to correcting human vision using technology licensed from the University of Rochester. The company is backed by over $15 million in venture capital and NSF funding.
Earlier, Mike co-founded iCardiac Technologies. In 2014, iCardiac was acquired in a control transaction by Norwest Venture Partners and was subsequently sold to ERT in 2017.
Before iCardiac, Mike was a founding executive of VirtualScopics. VirtualScopics became a public traded company in 2005 and was later sold to BioTelemetry.
Earlier in his career, Mike was a principal at 3Com Ventures, a $250 million venture capital fund based in Santa Clara, CA. Three out of four of his investments resulted in exits.
Mr. Totterman received his Engineering Degree from Stanford University and his MBA from the Business School at Dartmouth. Additionally, he serves on the Board of Directors for Qmetrics Technologies, Inc., a provider of imaging software and clinical trial solutions.
Strategic Partnering to Support Medical Device Development
To speed market introduction and reduce capital intensity, it's critical to consider how to best partner to deliver basic science, product design and development, initial and scale manufacturing, pre-clinical and clinical development, regulatory approval, distribution, sales and service.
Kevin Strange, President and CEO at Biolux Research
20 Year veteran of Vancouver Medical Device Start-ups
BASc (1992) and MASc (1996) from Simon Fraser University, School of Engineering Science
1996 - 1998 SFU / Neurostream (Vancouver, private co) – implantable devices for stimulating and recording peripheral nerves
1998 – 2005 VSM MedTech (Vancouver, public co) - vital signs monitors and functional brain imaging
2005 – 2008 StarFish Medical (Victoria, private co) - contract medical device design and manufacturing
2008 – current Biolux Research (Vancouver, private co) - light accelerated products for dentistry – www.bioluxresearch.com
My 20 years of Medical Device Start-ups in Vancouver
All my ventures were excellent ideas / tech with great promise for improving patient’s lives. Each also had challenges common to start-ups.
MICHAEL HOEY, Co-Founder & Chief Technology Officer, NxThera - Minneapolis
Expert in thermotherapy with 72 patents granted and 94 patents pending
Michael started as an academician who taught and performed research in several departments at the University of Minnesota: Physiology, Urologic Surgery, Engineering, and Management. He also taught in the department of Biological Sciences at Hamline University in St. Paul, Minnesota. Michael is an expert in thermal energy-tissue interaction, and a prolific inventor with over 80 patents granted and more than 90 patents pending, the majority in the medical device field. Michael’s inventions include platform technologies which are the foundation for products being sold or in development for cardiac surgery, oncology, orthopaedics, pulmonology, general surgery, urology, gynecology, and vascular surgery applications. Michael has been a founder/principal/inventor for several medical products companies, which combined have raised over $500 million of capital. Two of these companies, Vessix Vascular and recently NxThera sold to Boston Scientific, and Salient Surgical sold to Medtronic. He also sold a musical products company Ontek Inc. to Kyser, and reached a distribution deal with an agricultural diagnostic’s company, ASI, to one of the largest dairy products manufactures, GEA in Germany. Two other medical device companies, Aegea and Uptake, are commercializing product. Michael is also a general partner in Solas Bio-Ventures, a venture capital fund that makes investments in early stage biotech, medical device, and pharmaceutical businesses.
Case study: Applying orthopaedics technology to urology
PAUL WEBER, President and Chief Executive Officer Perimeter Medical Imaging - Toronto
Medical Device Marketing, International Distribution, and Business Development Expert
Mr. Weber brings extensive marketing, commercialization and international business development experience with both large multinational and growth stage medical and technology companies. Prior to joining Perimeter Medical, he led Business Development and Marketing for Covalon Technologies. In this capacity he helped to transition the company from a technology focus to a commercially focused organization, building out OEM, domestic and international distribution channels. At Sentinelle he led Business Development and Marketing, growing the company from start-up revenues to greater than $18 million in sales in 2 ½ years. After being acquired by Hologic Inc. for $105 million, Mr. Weber led Marketing, integration, and OEM and International Distribution relationships. Mr. Weber has also had leadership roles in business development and product management capacities with Johnson and Johnson, Christie Digital and has consulted for numerous technology start-ups on growth strategies. He has developed and taught MBA courses in Marketing and Commercialization of Technology and holds a BA in Psychology and an MBA from Wilfrid Laurier University.
Critical partnering considerations with case study illustration
DOUG GOERTZEN, CEO, Kardium - Vancouver
Local SFU EE grad now leading Medtech start-up
Doug Goertzen is the CEO of Kardium, a medical device company with a team of 120 developing an advanced ablation catheter for the treatment of atrial fibrillation. Doug has led the company since it was founded in 2007. Prior to Kardium, Doug held the position of General Manager, Proofing and Color at Eastman Kodak Company. Doug was responsible for the $55 million worldwide proofing and colour business and managed a 130 person team developing the proofing and colour product portfolio. He held senior positions in service, development and management during his 12 year tenure at Kodak and Creo Inc. (which was acquired by Kodak in 2005). Doug graduated with a B.A.Sc. in electrical engineering from Simon Fraser University.
Kardium – The journey of transforming a naïve idea into a commercial medical device
Exciting, frustrating, exhilarating, painful, and gratifying story of how the Kardium team created the most advanced therapeutic catheter ever.
SCOTT PHILLIPS, CEO, StarFish Medical - Victoria
Creator Medical Device Playbook
Scott holds a degree in Engineering Physics from the University of British Columbia. Prior to starting StarFish, he worked in diverse areas such as lithium battery development and manufacturing, UV spectroscopy instrumentation and hi-fi audio speakers. Under his leadership StarFish has grown into a diverse professional organization with clients around the world and 100% focus on medical devices. Scott is a Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, member of the LifeSciences British Columbia board, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.
What it takes to build a $100M Medical Device Product or Company
VESNA JANIC, Director of QA/RA StarFish Medical - Victoria
QA/RA responsible for 30+ concurrent medical devices and companies
Vesna’s expertise in regulatory compliance and conformance standards provides StarFish Medical’s clients with invaluable guidance and assistance in understanding and complying with regulatory standards such as cGMP, GLP, GCP, ISO 13485 and ISO 17025. Drawing upon her certification by the SQA as a Registered QA Professional in GLP and more than 17 years of experience in the R&D and QA fields, Vesna ensures that your StarFish project successfully meets and exceeds industry standards.
Terminal City Club
837 W Hastings Street
Vancouver BC V6C 1B6
The 2017 events in Toronto and Vancouver were a hit with 450+ participants, speakers, and sponsors. Veteran speakers providing industry insights and experience joined rooms full of the medical device entrepreneurs to exchange ideas and business cards in a day-long event designed specifically for local medtech innovators.
92% would recommend the event to friends
“It is the only ‘conference’ of its type in Canada. I really enjoyed that it was all about the business and commercialization aspects of the health-tech industry and not heavily based on technology.”